List of Tables
Table 1. Global Tourette Syndrome Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tourette Syndrome Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tourette Syndrome Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tourette Syndrome Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tourette Syndrome Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tourette Syndrome Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tourette Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tourette Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tourette Syndrome Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tourette Syndrome Drug, Product Type & Application
Table 12. Global Key Manufacturers of Tourette Syndrome Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tourette Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tourette Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Tourette Syndrome Drug Sales Market Share by Region (2020-2025)
Table 19. Global Tourette Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Tourette Syndrome Drug Sales Market Share by Region (2026-2031)
Table 21. Global Tourette Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tourette Syndrome Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Tourette Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tourette Syndrome Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Tourette Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tourette Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Tourette Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Tourette Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tourette Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tourette Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tourette Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Tourette Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Tourette Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tourette Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tourette Syndrome Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tourette Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Tourette Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Tourette Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tourette Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tourette Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tourette Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Tourette Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Tourette Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tourette Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tourette Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tourette Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Tourette Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tourette Syndrome Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Tourette Syndrome Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Tourette Syndrome Drug Sales Market Share by Type (2020-2025)
Table 53. Global Tourette Syndrome Drug Sales Market Share by Type (2026-2031)
Table 54. Global Tourette Syndrome Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tourette Syndrome Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tourette Syndrome Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Tourette Syndrome Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Tourette Syndrome Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Tourette Syndrome Drug Sales Market Share by Application (2020-2025)
Table 63. Global Tourette Syndrome Drug Sales Market Share by Application (2026-2031)
Table 64. Global Tourette Syndrome Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tourette Syndrome Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tourette Syndrome Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Tourette Syndrome Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Abide Therapeutics Inc Company Information
Table 71. Abide Therapeutics Inc Description and Business Overview
Table 72. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Abide Therapeutics Inc Tourette Syndrome Drug Product
Table 74. Abide Therapeutics Inc Recent Developments/Updates
Table 75. Catalyst Pharmaceuticals Inc Company Information
Table 76. Catalyst Pharmaceuticals Inc Description and Business Overview
Table 77. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 79. Catalyst Pharmaceuticals Inc Recent Developments/Updates
Table 80. Neurocrine Biosciences Inc Company Information
Table 81. Neurocrine Biosciences Inc Description and Business Overview
Table 82. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Neurocrine Biosciences Inc Tourette Syndrome Drug Product
Table 84. Neurocrine Biosciences Inc Recent Developments/Updates
Table 85. Psyadon Pharmaceuticals Inc Company Information
Table 86. Psyadon Pharmaceuticals Inc Description and Business Overview
Table 87. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 89. Psyadon Pharmaceuticals Inc Recent Developments/Updates
Table 90. Reviva Pharmaceuticals Inc Company Information
Table 91. Reviva Pharmaceuticals Inc Description and Business Overview
Table 92. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product
Table 94. Reviva Pharmaceuticals Inc Recent Developments/Updates
Table 95. Synchroneuron Inc Company Information
Table 96. Synchroneuron Inc Description and Business Overview
Table 97. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Synchroneuron Inc Tourette Syndrome Drug Product
Table 99. Synchroneuron Inc Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Ltd Company Information
Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product
Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 105. Therapix Biosciences Ltd Company Information
Table 106. Therapix Biosciences Ltd Description and Business Overview
Table 107. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Therapix Biosciences Ltd Tourette Syndrome Drug Product
Table 109. Therapix Biosciences Ltd Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Tourette Syndrome Drug Distributors List
Table 113. Tourette Syndrome Drug Customers List
Table 114. Tourette Syndrome Drug Market Trends
Table 115. Tourette Syndrome Drug Market Drivers
Table 116. Tourette Syndrome Drug Market Challenges
Table 117. Tourette Syndrome Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tourette Syndrome Drug
Figure 2. Global Tourette Syndrome Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tourette Syndrome Drug Market Share by Type: 2024 & 2031
Figure 4. AZD-5213 Product Picture
Figure 5. CPP-115 Product Picture
Figure 6. Dutetrabenazine ER Product Picture
Figure 7. Ecopipam Hydrochloride Product Picture
Figure 8. Others Product Picture
Figure 9. Global Tourette Syndrome Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Tourette Syndrome Drug Market Share by Application: 2024 & 2031
Figure 11. Research Center
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Tourette Syndrome Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tourette Syndrome Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Tourette Syndrome Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Tourette Syndrome Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Tourette Syndrome Drug Report Years Considered
Figure 20. Tourette Syndrome Drug Sales Share by Manufacturers in 2024
Figure 21. Global Tourette Syndrome Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Tourette Syndrome Drug Players: Market Share by Revenue in Tourette Syndrome Drug in 2024
Figure 23. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Tourette Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Tourette Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Tourette Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Tourette Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Tourette Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Tourette Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Tourette Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Tourette Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Tourette Syndrome Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Tourette Syndrome Drug by Type (2020-2031)
Figure 60. Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Tourette Syndrome Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Tourette Syndrome Drug by Application (2020-2031)
Figure 63. Global Tourette Syndrome Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Tourette Syndrome Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
